Overview
- 47 inspections across 46 sites are on record.
- 10 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-14.
At a glance
Inspections
47
Sites
46
Observations
10
Career since
Jun 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Philip Li, M.D. | 14 May 2026 | Human Drugs | |
| Harry Harinder Singh Gill, M.D. | 8 May 2026 | Human Drugs | |
| Bryan D. Springer, M.D. | 2 Apr 2026 | Human Drugs | |
| Michael D. Banov, MD | 23 Mar 2026 | Human Drugs | |
| Lexington Medical Center IRB | 26 Feb 2026 | Medical Devices & Rad Health |
Sites inspected
Philip Li, M.D.Hong Kong, China1 insp.
Harry Harinder Singh Gill, M.D.Hong Kong, China1 insp.
Bryan D. Springer, M.D.Charlotte, United States1 insp.
Michael D. Banov, MDMarietta, United States1 insp.
Lexington Medical Center IRBWest Columbia, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Christopher M Jeffers3 shared
Ann B Borromeo3 shared
Kellie R Riggs2 shared
Marshall A Naimo2 shared
Talia J Ferguson1 shared
Koffi A Amegadje1 shared
Dana M Klimavicz1 shared
Leon L Crawley1 shared
Laura L Staples1 shared
Full investigator report
Get the verbatim findings behind Matthew R Coleman's 10 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site